NCT02616783Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

Phase 3

NCT01745822Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Phase 3

+2 more

GeneXpert HCV VL Fingerstick test

Hepatitis C, Chronic

N/A

Clinical Trials (1)

NCT04610762HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

N/A

Digital nutritional program

Metabolic Dysfunction-Associated Steatotic Liver Disease

N/A

Clinical Trials (1)

NCT07456332Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease

N/A

Adaptability of an Undetectable = Untransmissible Model for HBV

Chronic Hepatitis b

N/A

Clinical Trials (1)

NCT07449091Adaptability of an Undetectable = Untransmissible Model for HBV

N/A

Biopsies and bloood samplings

HIV-1-infection

N/A

Clinical Trials (1)

NCT05222945A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

N/A

EC clinic support - whole of practice interventions delivery through nurse-led model

Hepatitis C

N/A

Clinical Trials (1)

NCT04061551Eliminate Hepatitis C/EC Partnership Evaluation Protocol

N/A

Burden of Hepatitis D Virus (HDV) Infection in Italy

Chronic Hepatitis D

N/A

Clinical Trials (1)

NCT05723068Burden of Hepatitis D Virus (HDV) Infection in Italy

N/A

Financial Incentive

Pre-Exposure Prophylaxis

N/A

Clinical Trials (1)

NCT03078153Effect of Social Media Support and Financial Incentives on PrEP Adherence

N/A

Remdesivir

COVID-19

N/A

Clinical Trials (1)

NCT04582266PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

N/A

Axicabtagene Ciloleucel

Large B-cell Lymphoma

N/A

Clinical Trials (1)

NCT05776160Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel

N/A

No intervention

Breast Cancer

N/A

Clinical Trials (2)

NCT00645736CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study

N/A

NCT06683482A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

N/A

Directly Observed Therapy

HEPATITIS C

N/A

Clinical Trials (1)

NCT02573376Antiviral Pharmacology and Adherence in Drug Users

N/A

Bulevirtide

Chronic Hepatitis Delta Virus Infection

N/A

Clinical Trials (1)

NCT06780579Expanded Access for Bulevirtide

N/A

B/F/TAF

HIV-1-infection

N/A

Clinical Trials (1)

NCT03580668Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide

N/A

The Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'

HIV Positive

N/A

GS-4774

Chronic Hepatitis B

N/A

Clinical Trials (1)

NCT02258581Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

N/A

Virtual clinical visits with home lab kits and mailed HIV PrEP

HIV Infections

N/A

Clinical Trials (1)

NCT05319613Reducing Disparities in Rural HIV Prevention

N/A

Rapid Treatment strategy

Hepatitis C

N/A

Clinical Trials (1)

NCT03627546HCV Seek, Test and Rapid Treatment for Young PWID

N/A

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-H

HIV Infections

N/A

Clinical Trials (1)

NCT00660361A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

N/A

SOF

Hepatitis C

N/A

Clinical Trials (1)

NCT02562742Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

N/A

ELISA testing

Hepatitis B

N/A

Clinical Trials (1)

NCT01767597Application of HBV Rapid Tests as a Tool for Wide-Use Screening

N/A

Idelalisib

Chronic Lymphocytic Leukaemia

N/A

Clinical Trials (1)

NCT03582098Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

N/A

Bulevirtide

Chronic Hepatitis D Infection

N/A

Clinical Trials (1)

NCT05718700Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

N/A

birth dose vaccination against hepatitis B strategy

Hepatitis B

N/A

Clinical Trials (1)

NCT04029454Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule

N/A

TelePrEP

Hiv

N/A

Clinical Trials (1)

NCT05520905TelePrEP for At-risk Youth in Colorado

N/A

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in th

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

N/A

Clinical Trials (1)

NCT02196064Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

N/A

Sofosbuvir

Hepatitis C Virus

N/A

Clinical Trials (1)

NCT02907996Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea

N/A

Biospecimen Collection

Absence of Signs or Symptoms

N/A

Clinical Trials (1)

NCT02928510Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

N/A

Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT01646541Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery

N/A

Evaluating the Chain of Addiction Care (CAC)

Hepatitis C, Chronic

N/A

Clinical Trials (1)

NCT05401136Evaluating the Chain of Addiction Care (CAC)